Navigation Links
Morphotek(R), Inc. Announces a Licensing Deal With Centocor Ortho Biotech Inc. for Exclusive Development and Commercialization Rights for a Therapeutic Monoclonal Antibody
Date:10/28/2009

EXTON, Pa., Oct. 28 /PRNewswire/ -- Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it has entered into a license agreement with Centocor Ortho Biotech Inc. for development and commercialization of an antibody that targets a tumor-associated antigen over-expressed in many solid tumors.

Under the terms of the agreement, Morphotek has been granted an exclusive worldwide license for the development, manufacture and sale of the antibody. Financial terms were not disclosed. Preclinical studies, conducted by Centocor Ortho Biotech, have shown that the relevant antigen is over-expressed in many solid tumors.

"We are delighted to conclude this license agreement with Centocor Ortho Biotech as we are committed to bringing healthcare solutions to cancer patients, especially for areas of unmet medical need," said Philip Sass, Ph.D., Chief Operating Officer of Morphotek. "Morphotek is well positioned to apply its technologies, knowledge and expertise in monoclonal antibody development for the development and commercialization of this antibody. The preclinical data package for this antibody have shown anti-cancer effects and we look forward to validating these in human trials."

About Morphotek

Morphotek®, Inc., a subsidiary of Eisai Inc., is a biopharmaceutical company specializing in the development of protein and antibody products through the use of novel and proprietary technologies. The technologies have been successfully applied to a variety of molecules that are suitable for pharmaceutical product development in the areas of antibody therapeutics, protein therapeutics, product manufacturing, drug target discovery, and improved output traits for commercial applications. The company is currently focusing its platform on the development and manufacturing of therapeutic antibodies for the treatment of cancer, inflammation and infectious disease. For more information, please vi
'/>"/>

SOURCE Morphotek(R), Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Morphotek(R), Inc. Announces FDA Acceptance of Investigational New Drug Application for MORAb-004, a Monoclonal Antibody for the Treatment of Solid Tumors
2. Morphotek(R), Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer
3. Connectyx Announces the MedFlash Personal Health Manager
4. Allegheny Medical Announces Launch of the New AlleghenyMedical.com
5. Zix Corporation Hits High End of Financial Guidance as Company Announces Third Quarter 2009 Financial Results
6. 1-800-Therapist Announces New Executive Team and Tele-Therapy Offering
7. Ziosoft Announces Agreement with Imaging & Medical Information Technology to Distribute Ziosoft's 3D Advanced Visualization Software in Turkey
8. Sorrento Therapeutics Announces the Appointment of Martina Molsbergen as Vice President, Business Development
9. CardioGenics Holdings Inc. Announces Name, Ticker Symbol and CUSIP Number Change
10. Spain-United States Chamber of Commerce Announces 30th Annual Gala Honoring IBT Group at The Biltmore Hotel - November 6
11. Akorn, Inc. Announces Third Quarter 2009 Earnings Release and Conference Call Information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... Salt Lake City,Utah (PRWEB) March 05, 2015 ... that manufactures microFET medical dynamometers, ergoFET physical ... acquisition systems with sensors for ergonomics, engineering, ... new microFET Digital Handgrip Dynamometer, available at ... Handgrip was designed to offer healthcare professionals ...
(Date:3/5/2015)... Saint John, New Brunswick (PRWEB) March 05, 2015 ... board to help validate product innovations as the company ... advisory board will be comprised of individuals in the ... approach to working with our clients,” said Elandas CEO ... to grow as a successful organization through our collaborative ...
(Date:3/4/2015)... The emergence of nanotechnology has ... past decade. The pharmaceutical world has witnessed advancements ... the form of liposomes and polymeric nanoparticles that ... safety and efficiency. In the area of ... upon the enhanced permeability and retention (EPR) effect ...
(Date:3/4/2015)... Ultraman Florida is a grueling extreme athletic ... bike, and 52.4 mile run. Christian Isakson finished in ... "This race was awesome and tough," Isakson said. "I ... for supporting me through every part of this brutal ... of 40 select participants invited from across the United ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 TROY Healthcare ... software, which provides the ultimate level of security for ... the Hilton Houston Plaza Medical Center located at 6633 ... , Beginning at 7 AM, TROY Healthcare Solutions will ... Healthcare Solutions will offer brief presentations each hour to ...
Breaking Medicine News(10 mins):Health News:New Handgrip Strength Tester Receives Rave Reviews At Physical Therapy Conference 2Health News:Elandas Creates Advisory Board to Help Guide Innovation 2Health News:Cancer Nanomedicine Marketplace Discussed by Kuick Research in Topical Study Recently Published at MarketPublishers.com 2Health News:Cancer Nanomedicine Marketplace Discussed by Kuick Research in Topical Study Recently Published at MarketPublishers.com 3Health News:Living Fuel Champion Christian Isakson Finishes Second In UltraMan Florida Test of Endurance 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 3
... be detected earlier using a computer-assisted detection system ( ... a computer-based analysis designed to find breast abnormalities. // ... as tiny white specks on mammography film. These tiny ... reviewed the cases of 519 patients with breast cancer. ...
... second-leading cause of cancer death in men and kills nearly ... one in six, is higher than the one in eight ... shows the rate of rise in prostate-specific antigen levels, or ... indicator of eventual death from prostate cancer than the actual ...
... saying that the gene known as “mighty mouse” might ... gene arose when a German neurologist , stumbled // on ... tests revealed the child had a mutation in his myostatin ... protein, which is known to regulate muscle growth. So far ...
... New research shows a significant improvement in treatment for a ... I seminoma is typically treated by // removal of the ... developing a second cancer in another organ up to 20 ... receive a single course of the drug carboplatin and more ...
... found to boost the immune system and help fight off ... on children already in the hospital with severe pneumonia// and ... children with severe pneumonia recover quicker . ,The study ... About half received 20 milligrams of zinc per day while ...
... for cosmetic purposes to erase the signs of aging. However ... toxin is being used to treat a chronic condition known ... of the stomach after a meal. It may be for ... by the patient.The condition causes a person to feel full ...
Cached Medicine News:
(Date:3/4/2015)... , March 4, 2015  Kannalife Sciences, Inc. ("Kannalife") ... joined its Scientific Advisory Board to assist the Company ... towards the use of cannabinoid therapeutics for the treatment ... forensic pathologist responsible for conducting the full autopsy of ... Fame center for the Pittsburgh Steelers. It was through ...
(Date:3/4/2015)... March 4, 2015  Halyard Health, Inc. (NYSE: ... provided its 2015 outlook and related key planning assumptions. ... Health as we report our fourth quarter results, our ... and CEO. "We executed a smooth separation from Kimberly-Clark ... spin-off. We delivered sales growth and margin improvement in ...
(Date:3/4/2015)... March 4, 2015  ECR Booth #317/Expo C - ... showcasing a full spectrum of X-ray imaging solutions that ... costs, and enable greater patient throughput for manufacturers of ... These solutions are on display at the Annual European ... Austria this week.   "This ...
Breaking Medicine Technology:Kannalife Sciences, Inc. Announces the Addition of Dr. Bennet Omalu, Renowned Pathologist and Founder of Chronic Traumatic Encephalopathy, to its Scientific Advisory Board 2Kannalife Sciences, Inc. Announces the Addition of Dr. Bennet Omalu, Renowned Pathologist and Founder of Chronic Traumatic Encephalopathy, to its Scientific Advisory Board 3Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 2Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 3Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 4Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 5Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 6Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 7Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 8Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 9Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 10Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 11Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 12Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 13Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 14Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 15Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 16Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 17Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 18Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 19Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 20Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 21Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 22Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 23Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 24Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 25Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 26Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 27Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 28Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 29Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 30Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 31Varian Medical Systems to Showcase New X-Ray Imaging Components at the European Congress of Radiology (ECR) Annual Meeting 2Varian Medical Systems to Showcase New X-Ray Imaging Components at the European Congress of Radiology (ECR) Annual Meeting 3
... UPI ), a medical device company ... to treat voiding dysfunctions, announced today that David ... President and CFO, will present the Company,s business ... 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Medical ...
... 2011 Merrimack Pharmaceuticals, Inc. announced today that the ... clinical study combining MM-121, a fully human monoclonal antibody ... regimens for patients with advanced solid tumors. ... study evaluates the safety and pharmacokinetics of MM-121 when ...
Cached Medicine Technology:Uroplasty to Present at the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Medical Device Conference 2
The cardiac blanket is pre-positioned at the waist during prep, unrolled upon closure of the saphenous vein graft incision, and inflated post-bypass....
The adult blanket provides full coverage for patients of all sizes. The generous size and versatility of these blankets include extra material for the shoulders and feet. The foot drape also reduces ...
The cath lab blanket, designed for use in the Cardiac Cath Lab, surrounds the patient with warm air and allows unrestricted access to the femoral artery....
The Bair Hugger outpatient blanket makes it easy to give your patients the benefit of prewarming and enhance patient comfort during outpatient procedures....
Medicine Products: